PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 228 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $229,000 | -6.9% | 5,615 | -11.9% | 0.01% | 0.0% |
| Q4 2022 | $246,000 | -28.3% | 6,371 | -1.2% | 0.01% | -40.0% |
| Q3 2022 | $343,000 | +6.9% | 6,446 | +17.2% | 0.02% | +15.4% |
| Q2 2022 | $321,000 | -26.7% | 5,502 | -4.1% | 0.01% | -13.3% |
| Q1 2022 | $438,000 | +3.8% | 5,735 | -18.1% | 0.02% | +15.4% |
| Q4 2021 | $422,000 | +6.8% | 7,006 | -0.7% | 0.01% | -7.1% |
| Q3 2021 | $395,000 | -7.3% | 7,057 | +0.6% | 0.01% | 0.0% |
| Q2 2021 | $426,000 | -15.1% | 7,016 | -2.1% | 0.01% | -17.6% |
| Q1 2021 | $502,000 | +15.1% | 7,166 | -1.6% | 0.02% | +13.3% |
| Q4 2020 | $436,000 | -0.7% | 7,282 | -0.4% | 0.02% | -6.2% |
| Q3 2020 | $439,000 | +19.0% | 7,309 | +4.1% | 0.02% | +14.3% |
| Q2 2020 | $369,000 | +13.9% | 7,024 | -27.2% | 0.01% | +7.7% |
| Q1 2020 | $324,000 | – | 9,649 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Key Colony Management, LLC | 134,600 | $13,045,000 | 11.31% |
| Biondo Investment Advisors, LLC | 279,717 | $27,110,000 | 8.33% |
| GILDER GAGNON HOWE & CO LLC | 3,177,130 | $307,927,000 | 4.48% |
| DARUMA CAPITAL MANAGEMENT LLC | 814,470 | $78,938,000 | 3.47% |
| MAGEE THOMSON INVESTMENT PARTNERS LLC | 126,022 | $12,214,000 | 3.01% |
| NEXT CENTURY GROWTH INVESTORS LLC | 768,396 | $74,472,000 | 2.63% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 180,000 | $17,446,000 | 2.38% |
| Lisanti Capital Growth, LLC | 48,280 | $4,679,000 | 2.35% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 79,017 | $7,658,000 | 2.00% |
| Atika Capital Management LLC | 21,500 | $2,084,000 | 1.60% |